Search clinical trials for: Diroximel Fumarate

Total 1569 results

Gilead Sciences

Completed

Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

HIV Infections | Acquired Immunodeficiency Syndrome

United States
Biogen

Completed

Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Czech Republic, Poland, Slovakia, India, Australia, Canada
Gilead Sciences
National Institute on Drug Abuse (NIDA); National Institute of Allergy and... and other collaborators

Recruiting

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) (PURPOSE 4)

Pre-Exposure Prophylaxis of HIV Infection

United States
National Institute of Allergy and Infectious Diseases...
Adult AIDS Clinical Trials Group

Completed

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

HIV Infections

United States
Central Hospital, Nancy, France

Completed

Multiple Sclerosis: Chi3L1 and Treatment Efficacy

Multiple Sclerosis
University of Colorado, Denver

Completed

Bioequivalence of Tenofovir and Emtricitabine Following Overencapsulation (A-TEAM)

Healthy Volunteers | Pharmacokinetics
AstraZeneca
QuintilesIMS, Inc.

Withdrawn

To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease (ASTUTE)

Chronic Obstructive Pulmonary Disease
Community Research Initiative of New England
Merck Sharp & Dohme LLC

Withdrawn

A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells

HIV Infections | Acquired Immune Deficiency Syndrome
Sichuan University

Unknown

Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia

Acute Schizophrenia

China
MRC/UVRI and LSHTM Uganda Research Unit
London School of Hygiene and Tropical Medicine; Assistance Publique - Hôpitaux... and other collaborators

Not yet recruiting

Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa (MOBILEMEN)

HIV
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.

Liver Fibrosis

China
McGill University Health Centre/Research Institute...

Completed

The Effects of Inhaled Aclidinium Bromide/Formoterol Fumarate on Inspiratory Pleural Pressures in Smokers

Smoking

Canada
Ain Shams University

Unknown

Amino Acid Chelated Iron Versus Ferrous Fumarate in the Treatment of Iron Deficiency Anemia With Pregnancy: Randomized Controlled Trial

Iron Deficiency Anemia

Egypt
Mundipharma Research Limited

Completed

Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma (FLT2503)

Asthma

Germany
Guang Dong Provincial Mental Health Institute

Completed

A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia

Schizophrenia

China
Novartis
Schering-Plough

Completed

Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers

Healthy

United Kingdom
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

HIV Infections

Peru, Brazil, South Africa, Uganda, Botswana, Haiti, Zambia, Zimbabwe
Pearl Therapeutics, Inc.

Completed

Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Astellas Pharma Inc

Completed

Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Bipolar Depression

Japan
Midtown Medical Center, Tampa, FL
Gilead Sciences

Completed

Atripla to Stribild Switch Study to Evaluate Sleep Disturbances

HIV | Sleep Disorders | AIDS
Mclean Hospital

Terminated

Generalized Anxiety and Seroquel (GAD)

Generalized Anxiety Disorder | Seroquel XR

United States
Cambridge Health Alliance
AstraZeneca

Completed

Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults

Social Anxiety Disorder

United States
University of Cincinnati
National Institutes of Health (NIH)

Completed

Functional and Neurochemical Brain Changes in First-episode Bipolar Mania

Bipolar Disorder

United States
Seoul National University Hospital

Unknown

Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients

Delirium
East Tennessee State University
AstraZeneca

Completed

Quetiapine Compared With Placebo in the Management of Fibromyalgia

Fibromyalgia

United States
AstraZeneca

Completed

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Schizophrenia

United States, Bulgaria, Spain, Estonia, Hungary, Latvia, Finland, Canada, Germany, Italy, Lithuania, Australia
Corporation de Recherche en Neuropsycho Pharmacologie...

Unknown

Clinical Benefits of Seroquel XR in Anxiety Disorder

Schizophrenia | Anxiety

Canada
Massachusetts General Hospital

Completed

Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder

Bipolar Disorder | Mania
Hannover Medical School
AstraZeneca

Terminated

Quetiapine XR in Schizophrenic Patients

Schizophrenia

Germany
University Hospital, Antwerp
AstraZeneca

Completed

Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients.

Chronic Obstructive Pulmonary Disease

Belgium
AstraZeneca

Completed

Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study

Obsessive Compulsive Disorder

Netherlands
AstraZeneca

Completed

Seroquel- Agitation Associated With Dementia

Vascular Dementia | Alzheimer's Disease
AstraZeneca

Completed

Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients. (PLATINUM)

Anxiety Disorders

United States, Korea, Republic of, Russian Federation, United Kingdom, Germany, Philippines, Hungary, Finland, Canada, Australia, Indonesia
Solvay Pharmaceuticals
Wyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/S

Terminated

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Schizophrenia

United States, Argentina, Canada, Chile, Czech Republic, Estonia, Finland, Germany, Hungary, Latvia, Lithuania, Peru, Slovakia, South Africa
King's College London
University of Oxford; Newcastle University; South London and Maudsley NHS Foundation... and other collaborators

Recruiting

Lithium Versus Quetiapine in Treatment Resistant Depression (LQD)

Depressive Disorder, Treatment-Resistant

United Kingdom
Medical College of Wisconsin

Withdrawn

Quetiapine Treatment for Pediatric Delirium

Delirium

United States
Astellas Pharma Inc

Completed

Long-term Study of FK949E in Elderly Bipolar Disorder Patients

Bipolar Disorder | Elderly

Japan
Cambridge Health Alliance

Completed

Post-Traumatic Stress Disorder (PTSD) and Seroquel

Post-Traumatic Stress Disorder

United States
Almirall, S.A.
Harrison Clinical Research; Almirall Hermal GmbH

Completed

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

Plaque Psoriasis

Austria, Germany, Netherlands, Poland
University of Tennessee Graduate School of Medicine

Completed

Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients

Psychomotor Agitation

United States
AstraZeneca

Completed

Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia

Schizophrenia

Hungary, Finland, Canada, Germany
AstraZeneca

Completed

Seroquel on Glucose Metabolism

Schizophrenia

Bulgaria, Czech Republic, South Africa, United Kingdom, Germany, Hungary, Romania, Slovakia, Norway
AstraZeneca

Completed

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Schizophrenia

Bulgaria, Poland
AstraZeneca

Completed

Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder (MANIA)

Acute Mania in Bipolar Disorder

China
AstraZeneca

Completed

Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder Patients (STAR)

Bipolar Disorder | Mania

China
University of British Columbia
AstraZeneca

Completed

The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression

Unipolar Depression

Canada
University of Medicine and Dentistry of New Jersey
AstraZeneca

Completed

Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder

Borderline Personality Disorder

United States
Khon Kaen University

Completed

Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial

Primary Insomnia

Thailand
Université de Montréal
AstraZeneca

Completed

The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients

Schizophrenia | Substance Use Disorders

Canada
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Doravirine for Persons With Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide

HIV Infections

United States

Search clinical trials for: Diroximel Fumarate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations